Fortrea Holdings FTRE
NASDAQ FTRE
$18.16 -0.46 (-2.47%)
As of: Sep 4, 2026 · 1:30 PM EDT

Fortrea Holdings (FTRE) Exchange Rate Effect (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Exchange Rate Effect came in at -$800000.0 in Q2 2026, down 118.6% YoY from $4.3 million in Q2 2025, and up 61.9% on a QoQ basis from -$2.1 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Exchange Rate Effect (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of Exchange Rate Effect data on file, last reported at -$800000.0 in Q2 2026.

  • Quarterly Exchange Rate Effect fell 118.6% year-over-year to -$800000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$5.5 million (down 225.0% YoY) and the FY2025 annual result came in at $4.5 million, up 167.16% from the prior year.
  • Exchange Rate Effect rose to -$800000.0 in Q2 2026, from -$2.1 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $4.3 million in Q2 2025 to a low of -$6.3 million in Q4 2024.
  • A 5-year average of -$300000.0 and a median of -$800000.0 in 2026 frame the typical range for Exchange Rate Effect.
  • Annual changes were most pronounced in 2024 — Exchange Rate Effect plunged 750.0% — and 2025, when it soared 352.94%.
  • Tracing FTRE's Exchange Rate Effect over 5 years: stood at $3.7 million in 2022, then declined by 16.22% to $3.1 million in 2023, then plunged by 303.23% to -$6.3 million in 2024, then soared by 58.73% to -$2.6 million in 2025, then jumped by 69.23% to -$800000.0 in 2026.
  • The last three Exchange Rate Effect figures came in at -$800000.0 (Q2 2026), -$2.1 million (Q1 2026), and -$2.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn -3.70 Mn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn -300,000.00
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn -2.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 19.84 Mn
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn -2.45 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -287,000.00
10 Fortrea Holdings 1.72 Bn 1.55 Bn 139.20 Mn -800,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -800,000.00
Mar 31, 2026 -2.10 Mn
Dec 31, 2025 -2.60 Mn
Jun 30, 2025 4.30 Mn
Mar 31, 2025 2.80 Mn
Dec 31, 2024 -6.30 Mn
Sep 30, 2024 3.60 Mn
Jun 30, 2024 -1.70 Mn
Mar 31, 2024 -2.30 Mn
Dec 31, 2023 3.10 Mn
Sep 30, 2023 -2.00 Mn
Jun 30, 2023 -200,000.00
Mar 31, 2023 1.50 Mn
Dec 31, 2022 3.70 Mn
Sep 30, 2022 -5.50 Mn